Ozempic vs Wegovy for weight loss: which do online clinics prescribe more easily?

Short answer: online clinics generally find it easier to prescribe Ozempic (semaglutide formulated/marketed for diabetes) or other semaglutide products off‑label for weight loss than to prescribe Wegovy, which is the FDA‑approved brand for chronic weight management and is subject to stricter access, prior‑authorization, cost, and supply constraints.

Why:

• Indication and labeling: Wegovy (semaglutide 2.4 mg) is FDA‑approved specifically for weight management and clinics must follow its label and payer rules. Ozempic (semaglutide 0.5–2.0 mg) is FDA‑approved for type 2 diabetes but is commonly used off‑label for weight loss.
• Availability and cost: Wegovy has been in limited supply and is more expensive; insurers often require prior authorization and documentation (BMI, comorbidities, prior attempts). Ozempic (and generic/compounded semaglutide formulations or lower‑dose prescriptions) are often easier for telehealth clinicians to obtain for patients.
• Clinic practice variation: many telemedicine weight‑loss programs will prescribe semaglutide/Ozempic or compounded semaglutide because it’s easier to access or bill. Clinics that emphasize comprehensive obesity care (coaching, metabolic evaluation) may be more likely to pursue Wegovy when appropriate.

Examples of telehealth services (practices vary—always confirm with the provider):

• Ro (Roman) — offers GLP‑1 programs and has prescribed semaglutide/tirzepatide in some programs.
• Hims & Hers — lists semaglutide/tirzepatide options for weight loss through their telehealth service.
• PlushCare — offers weight‑loss visits that may result in GLP‑1 prescriptions.
• Calibrate, Form (or similar dedicated tele‑weight programs) — are structured weight‑management programs that may pursue FDA‑approved Wegovy when clinically indicated, or use other GLP‑1s depending on availability/insurance.

Safety/monitoring note: regardless of online or in‑person, responsible providers will screen for contraindications (pregnancy, personal/family history of medullary thyroid carcinoma/MEN2, pancreatitis risk), review medications, and arrange follow‑up and labs.

Practical tips if you want Wegovy specifically:

• Ask the clinic up front “Will you prescribe Wegovy specifically, or only Ozempic/other semaglutide/compounded products?”
• Ask about insurance/price, prior‑auth assistance, and expected monitoring.
• If a clinic refuses Wegovy but you want that FDA‑approved option, ask for a referral to a local obesity medicine specialist or a clinic that advertises Wegovy access.

Bottom line: for easier, faster access via online clinics, Ozempic/other semaglutide products are more commonly prescribed; obtaining Wegovy is possible but often harder, more expensive, and slower.